Drug Guide
Paramethadione
Classification
Therapeutic: Anticonvulsant
Pharmacological: Im ido-dione derivative, sodium channel blocker
FDA Approved Indications
- Partial seizures
- Generalized tonic-clonic seizures
Mechanism of Action
Paramethadione stabilizes neuronal membranes and inhibits repetitive firing by blocking sodium channels, thereby reducing seizure activity.
Dosage and Administration
Adult: Initial dose: 30 mg/kg/day divided into 2-3 doses. Adjust based on response and tolerability.
Pediatric: Starting dose typically 15-20 mg/kg/day in divided doses, titrated up as needed.
Geriatric: Use with caution; start at lower doses and titrate slowly due to decreased hepatic function and comorbidities.
Renal Impairment: Adjust dose based on renal function; specific guidelines not well established.
Hepatic Impairment: Use with caution; hepatic metabolism may be reduced.
Pharmacokinetics
Absorption: Well absorbed orally
Distribution: Widely distributed, crosses the blood-brain barrier
Metabolism: Primarily hepatic, via conjugation and oxidation
Excretion: Renally excreted mainly as conjugates
Half Life: Approximately 20-40 hours, allowing for once or twice daily dosing
Contraindications
- Hypersensitivity to paramethadione or other hydantoins
- Bone marrow depression
- Porphyria
Precautions
- Use with caution in hepatic dysfunction, pregnancy, and lactation; careful monitoring required.
Adverse Reactions - Common
- Drowsiness (Common)
- Dizziness (Common)
- Gastrointestinal upset (Common)
Adverse Reactions - Serious
- Blood dyscrasias (aplastic anemia, leukopenia, thrombocytopenia) (Rare)
- Hepatotoxicity (Rare)
- Stevens-Johnson syndrome (Rare)
Drug-Drug Interactions
- Valproic acid (may increase levels)
- Other anticonvulsants (additive CNS depression)
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor seizure control, side effects, blood counts, liver function tests.
Diagnoses:
- Impaired skin integrity due to allergic reactions
- Risk for bleeding due to blood dyscrasias
Implementation: Administer with food to minimize gastrointestinal upset. Regularly monitor blood counts and liver function.
Evaluation: Assess seizure frequency and side effects; adjust dosage accordingly.
Patient/Family Teaching
- Take medication exactly as prescribed.
- Report signs of allergic reactions, bleeding, or liver problems.
- Avoid alcohol and CNS depressants; inform about potential drowsiness.
Special Considerations
Black Box Warnings:
- Serious blood dyscrasias and hepatotoxicity, though rare.
Genetic Factors: None specifically established.
Lab Test Interference: May cause false positive for urinary ketones.
Overdose Management
Signs/Symptoms: Drowsiness, nystagmus, coma, seizures.
Treatment: Supportive care; activated charcoal if recent ingestion; hemodialysis may be considered in severe cases.
Storage and Handling
Storage: Store at room temperature, away from light and moisture.
Stability: Stable under recommended conditions, check expiration date.